Introduction {#Sec1}
============

Serotonin has long been implicated in aversive processing. Individuals with enhanced aversive processing, such as those with depression or anxiety, exhibit altered serotonin function (Deakin and Graeff [@CR16]), and serotonin has been argued to provide an aversive opponent to dopamine-related appetitive responses (Boureau and Dayan [@CR4]; Cools et al. [@CR11]; Daw et al. [@CR13]). In 2008, we published a paper (Cools et al. [@CR10]) demonstrating that acute tryptophan depletion (ATD), associated with global reduction in central serotonin levels (Crockett et al. in submission; Gessa et al. [@CR20]; Young and Gauthier [@CR32]), enhanced punishment, but not reward prediction in healthy individuals. These findings provided clear experimental evidence for a valence-specific role of serotonin in aversive processing.

However, serotonin also plays a key role in reducing motor output and behavioural inhibition (Soubrié [@CR29]), and it has been argued that aversive processing and inhibition cannot easily be separated (Cools et al. [@CR11]; Dayan and Huys [@CR14]). The prepotent response to aversive stimuli across the animal kingdom, for instance is behavioural inhibition and withdrawal (Dayan and Huys [@CR15]). A recent computational model therefore sought to formally define this relationship (Dayan and Huys [@CR14]). In this model, serotonin acts to inhibit punishment-associated internally directed thoughts, thus pruning away aversive branches of a Markov decision tree. Recent experimental findings have provided support for this model (Crockett et al. [@CR12]). Using a novel task designed to disentangle inhibition and aversive responses, Crockett et al. showed that tryptophan depletion had no effect on (1) general motor inhibition or (2) sensitivity to aversive outcomes, but *did* (3) selectively reduce punishment-induced inhibition. As such, serotonin was critical for *neither* punishment processing, *nor* behavioural inhibition alone, but was specifically critical for punishment-induced inhibition.

In light of these recent studies, we sought to extend our previous findings by increasing the sample size and by examining the impact of mood state on the role of serotonin in punishment-induced inhibition. Specifically, recent reviews have sought to cast doubt over the effects of ATD on central serotonin transmission (Feenstra and van der Plasse [@CR19]; van Donkelaar et al. [@CR30]) (but see also (Crockett et al. in submission; Gessa et al. [@CR20]; Williams et al. [@CR31])). Replicating our previous valence-specific effect, which mimics the effects of other more direct serotonin manipulations (Cools et al. [@CR9]; Crockett et al. in submission), in a separate and larger sample should go some way towards allaying these concerns. Moreover, these reviews suggested that altered mood states may explain some of the effects of tryptophan depletion (Feenstra and van der Plasse [@CR19]; van Donkelaar et al. [@CR30]). As such, we sought to assess the impact of subject mood state on this effect. We have previously shown that mood state can modulate the role of ATD on some, (Robinson et al. [@CR25]) but not all (Robinson and Sahakian [@CR24]) cognitive tasks. In particular, mood state does not appear to modulate the role of ATD on the inhibition of aversive go/no-go responses (Robinson and Sahakian [@CR24]). As such, we predicted that mood would not modulate the effect of ATD on affective inhibition, thereby arguing against a universal role of mood in the effects of tryptophan depletion on cognitive processing.

Healthy female subjects (*N* = 41) undergoing either ATD or a balanced (BAL) procedure in a between-subjects design completed the reward and punishment reversal learning task adopted in our first study. Half of each group also received negative, and half neutral, mood induction procedures (MIP). We predicted that ATD would enhance aversive processing by abolishing a positive bias (i.e. increased punishment errors) present under balanced conditions (Cools et al. [@CR10]), and that this would be insensitive to mood state (Robinson and Sahakian [@CR24]).

Methods {#Sec2}
=======

Procedures were approved by the Cambridge Research Ethics Committee (06/Q0108/160) and were in accord with the Helsinki Declaration of 1975. All subjects were screened for psychiatric and neurological disorders, gave written informed consent and were compensated for participation. Exclusion criteria were cardiac, hepatic, renal, pulmonary, neurological, psychiatric or gastrointestinal disorders, drug use and personal or family history of any depressive disorder. Subjects were instructed to abstain from alcohol, caffeine and food from midnight prior to each session. Forty-two female subjects (to avoid gender confounds often seen in ATD) were recruited. One subject did not complete testing. The remaining 41 subjects were then divided into four groups: (1) ATD subjects who underwent negative MIP (*N* = 11), (2) ATD subjects who underwent neutral MIP (*N* = 10), (3) BAL subjects who underwent negative MIP (*N* = 10), (4) BAL subjects who underwent neutral MIP (*N* = 10). Subjects completed a number of state and trait measures; the Beck Depression Inventory (BDI; (Beck et al. [@CR2])), the Impulsiveness, Venturesomeness and Empathy questionnaire (IVE; (Eysenck and Eysenck [@CR18])) and the Behavioural Inhibition/Behavioural Activation Scale (BIS/BAS (Carver and White [@CR6])). The groups were demographically matched (see Table [1](#Tab1){ref-type="table"}) and within the same phase of menses (*t*~37~ = −0.3, *p* = 0.8). All subjects also completed a second test session (not presented here, see (Robinson and Sahakian [@CR23])). Table 1Demographic characteristicsMeanS.D.*P*Age27.66.40.3BDI4.54.10.4Impulsiveness6.54.10.2Venturesomeness8.53.70.2Empathy13.53.70.8BIS21.13.40.4BAS-drive11.72.10.2BAS-fun12.32.10.8BAS-reward16.92.00.9Non-significant *P* values indicate a lack of group effect on any of these variables

Procedure {#Sec3}
---------

Subjects arrived at the research centre between 0830 and 1030 hours and consumed the amino acid mixture. A blood sample was taken, and a nutritionally balanced (BAL) or a tryptophan free (ATD) amino acid drink was ingested. Following this, they were allowed to consume water and were given a low-protein snack (an apple) for lunch. After a resting period of approximately 5 h to ensure stable and low tryptophan levels (Carpenter et al. [@CR5]), a second blood sample was taken, and the MIP was completed. The MIP was followed by neuropsychological task completion.

Amino acid mixtures {#Sec4}
-------------------

Amino acid mixtures (prepared by SHS international; Liverpool, UK) were identical to previous research (Cools et al. [@CR10]; Crockett et al. [@CR12]; Robinson and Sahakian [@CR23]; Roiser et al. [@CR28]): [l]{.smallcaps}-alanine, 2.9 g; [l]{.smallcaps}-arginine, 2.6 g; [l]{.smallcaps}-cystine, 1.4 g; glycine, 1.7 g; [l]{.smallcaps}-histidine, 1.7 g; [l]{.smallcaps}-isoleucine, 4.2 g; [l]{.smallcaps}-leucine, 7.1 g; [l]{.smallcaps}-lysine, 4.7 g; [l]{.smallcaps}-methionine, 1.6 g; [l]{.smallcaps}-proline, 6.4 g; [l]{.smallcaps}-phenylalanine, 3.0 g; [l]{.smallcaps}-serine, 3.6 g; [l]{.smallcaps}-threonine, 3.4 g; [l]{.smallcaps}-tyrosine, 3.6 g; [l]{.smallcaps}-valine, 4.7 g; [l]{.smallcaps}-tryptophan, 2.1 g---total BAL, 54.7/TRP, 52.6 g. The drinks were prepared by stirring the mixture into approximately 200 ml tap water with either lemon-lime or grapefruit flavouring. Subjects reported no side effects apart from transient nausea following ingestion of the drink. Blood samples were analysed for the crucial TRP/sum of the long neutral amino acids (ΣLNAA) ratio.

Mood induction procedure {#Sec5}
------------------------

The MIP (Robinson and Sahakian [@CR23], [@CR24]; Robinson et al. [@CR25]) required subjects to relate negative or neutral Velten sentences to situations in their own lives whilst listening to mood-congruent music. It was programmed in Microsoft Visual Basic 6 and presented on a PaceBlade tablet computer (11-in. monitor). A set of visual analogue scales was administered (T1) at admission, (T2) 5 h later pre-MIP and (T3) post-MIP to determine self-reported mood.

Neuropsychological testing {#Sec6}
--------------------------

The ability to learn and update reward and punishment predictions was measured using a deterministic reversal learning paradigm employed previously (Cools et al. [@CR8], [@CR10]; Robinson et al. [@CR26]). Subjects were presented with two stimuli---one scene and one face. At any given point in time, one stimulus was associated with reward, whilst the other was associated with punishment. On each trial, one stimulus was highlighted by a thick black border and subjects had to predict whether the highlighted stimulus would lead to reward or punishment. They made their prediction by pressing one of two keys (one for punishment, one for reward; order counterbalanced) on a keyboard prior to receiving feedback. Subjects were then shown the actual outcome. Reward consisted of a green smiley face, a '+\$100' sign and a high-frequency jingle tone. Punishment consisted of a red sad face, a '−\$100' sign and a single low-frequency tone. The outcomes did not serve as direct performance feedback or as reinforcement. Instead subjects inferred whether their response was correct or not by remembering the key that the pressed (reward or punishment) and comparing it to the actual outcome. The stimulus-outcome contingencies reversed multiple times following attainment of a variable learning criterion (range from five to nine trials). Note that during training, subjects practiced the task until they learned that the outcomes were not performance feedback. However, if they erroneously began to consider the outcomes as performance feedback, they would not reach the learning criterion, and the task would never reverse.

There were two types of experimental condition. In the reward condition, reversals were signalled by providing subjects with unexpected reward following a stimulus previously associated with punishment (i.e. subjects predicted punishment based upon the previous trials, but the stimulus was unexpectedly followed by reward). Conversely, in the punishment condition, reversals were signalled by unexpected punishment. The maximum number of reversal stages per experimental block was 16, although the block terminated automatically after completion of 120 trials (6.6 min). Subjects completed two blocks of reward reversals and two blocks of punishment reversals. Thus, each subject performed 480 trials (four blocks) per experimental session. The order of valance conditions was counterbalanced between subjects.

As previously, performance was assessed by examining proportional errors on four trial types (Cools et al. [@CR10]): (1) *non-reversal reward trials* (defined as all trials that required reward prediction, but no updating of stimulus-outcome associations; only trials that followed correct expected outcome predictions were included); (2) *non-reversal punishment trials* (defined as above, but requiring punishment prediction); (3) *reward reversal trials* (defined as the trial that followed unexpected reward); (4) *punishment reversal trials* (defined the trial that followed unexpected punishment). Unexpected reward trials were collapsed across the two unexpected reward blocks (and vice versa for punishment). Reversal and non-reversal trials were assessed using separate repeated measures ANOVAs. Error rates were transformed into proportional scores and arcsine transformed (2\*arcsine (√*x*)). These transformed proportional scores were submitted to a repeated measures ANOVA with valence condition (two levels: unexpected reward and unexpected punishment) and trial-type (three levels: reversal, non-reversal reward and non-reversal punishment) as within-subjects factors and drink (two levels) and mood (two levels) as between-subjects factors. Simple effects analyses were Bonferroni corrected.

Results {#Sec7}
=======

Amino acid mixtures {#Sec8}
-------------------

Amino acid data (Table [2](#Tab2){ref-type="table"}) were incomplete for three (one ATD and two BAL) participants due to blood extraction problems. A repeated measures ANOVA revealed a significant two-way drink × time interaction for the critical TRP/ΣLNAA ratio (treatment × time; *F*~1,36~ = 66; *P* \< 0.001). Simple effects analyses revealed that the significant drink × time interaction was due to a 92% decrease in the TRP/ΣLNAA ratio following ATD (significant effect of time, *F*~1,36~ = 42; *P* \< 0.001) but a 92% increase in the TRP/ΣLNAA ratio following BAL (*F*~1,36~ = 26; *P* \< 0.001). Table 2Mood ratingsManipulationBeforeAfterATD5.8(0.4)5.2(0.4)BAL5.6(0.4)5.5(0.4)Negative MIP5.2(0.4)4.0(0.4)Neutral MIP5.5(0.4)5.3(0.4)Distance (centimetre) marked along a 10-cm visual analogue scale asking 'how happy are you?' Treatment effects are assessed prior to the MIP, and MIP effects are collapsed across treatment sessions

Mood change {#Sec9}
-----------

There was no change in sad mood state between the start of the experiment (T1) and 5 h later (T2) in either the ATD (*F*~1,35~ = 2) or BAL (*F*~1,35~ = 1) group (Table [2](#Tab2){ref-type="table"}). However, there was a significant increase in sad mood after the sad MIP (T3) relative to (T2) (*F*~1,36~ = 11, *P* = 0.003), but not before and after the neutral MIP (*F*~1,36~ = 1) (Table [2](#Tab2){ref-type="table"}). Thus, the MIP, but not the drink, altered participant\'s mood state.

Neuropsychological testing {#Sec10}
--------------------------

Pooling all trial types (reversal, non-reversal reward and non-reversal punishment) together revealed a significant drink (ATD, BAL) by valence condition (reward, punishment) interaction (*F*~1,35~ = 4.7, *P* = 0.04). There was also a significant valence condition by trial type (reversal, non-reversal reward block, non-reversal punishment block) interaction (*F*~2,34~ = 3.5, *P* = 0.04). As such, in line with our previous study, we next examined the reversal and non-reversal stages separately.

**Non-reversal trials** Non-reversal errors (Table [3](#Tab3){ref-type="table"}) were examined using an ANOVA with trial type (non-reversal reward, non-reversal punishment) and valence condition (reward reversal, punishment reversal) as within-subjects factors, and drink (ATD, BAL) and MIP (neutral, negative) as between-subjects factors. Consistent with our previous study (Cools et al. [@CR10]), there was a significant interaction between drink and trial type (*F*~1,35~ = 4.4, *P* = 0.04), which was driven by a significant effect of drink on punishment non-reversal trials (*F*~1,35~ = 4.3, *P* = 0.04), but not on reward non-reversal trials (*F*~1,35~ = 1.0). Moreover, subjects made significantly more errors on punishment than reward non-reversal trials after the BAL drink (*F*~1,35~ = 15.4, *P* \< 0.001) while there was no difference between punishment and reward non-reversal trials after ATD (*F*~1,35~ = 1.3; Fig. [1](#Fig1){ref-type="fig"}). This effect was, however, robust across mood state (no MIP × trial type × outcome interaction, *F*~1,35~ = 0.009) and valence condition (no valence condition × trial type × outcome interaction, *F*~1,35~ = 0.007). Table 3Error ratesNon-reversalRewardPunishmentGroupATD−ATD=BAL−BAL=ATD−ATD=BAL−BAL=Mean0.0360.0370.0580.0370.0370.0460.1160.074SEM0.0110.0100.0110.0110.0280.0270.0300.030ReversalMean0.0960.0890.0700.1190.0330.0430.0760.135SEM0.0380.0370.0410.0410.0450.0430.0480.048*ATD* acute tryptophan depletion, *BAL* balanced drink, − negative mood induction, = neutral mood induction. (ATD−: *n* = 10, ATD=: *n* = 11, BAL−: *n* = 9; BAL=: *n* = 9), *SEM* standard error of the mean

**Reversal trials** Reversal errors (Table [3](#Tab3){ref-type="table"}) were examined in an ANOVA with valence condition (reward reversal, punishment reversal) as a within-subject factor and drink (ATD, BAL) and MIP (neutral, negative) as between-subjects factors. Consistent, again, with our prior study, there was no drink by valence condition interaction (*F*~1,35~ = 3.1). Moreover, this effect was robust across mood state (MIP × drink × valence condition interaction, *F*~1,35~ = 0.1).Thus, as before, ATD abolished a disproportionate difficulty with punishment prediction, but did not affect reward prediction. This effect was restricted to the non-reversal trials, and was robust across mood states.

Discussion {#Sec11}
==========

The present results demonstrate that acute tryptophan depletion abolishes a disproportionate inability to predict punishment which is present following consumption of a balanced amino acid drink. This replicates our previous finding (Cools et al. [@CR10]) in an independent and larger sample of subjects and using a different between-subjects experimental design. Moreover, the finding extends prior work by suggesting that this effect on punishment prediction, unlike more complex cognitive effects of tryptophan depletion (Robinson et al. [@CR25]), may be impervious to subject mood state.

Previously, we postulated that the ATD-induced improvement in punishment prediction might represent enhanced aversive temporal-difference prediction error signals, brought about by lowering tonic 5-HT levels and increasing the signal-to-noise ratio of phasic 5-HT bursts (Cools et al. [@CR10]). In light of recent theoretical (Dayan and Huys [@CR14], [@CR15]) and experimental approaches (Crockett et al. [@CR12]), however, an alternative explanation might be that reducing serotonin attenuated punishment-induced inhibition. In the theoretical model proposed by Dayan and Huys ([@CR14]), serotonin is said to 'prune' aversive branches of 'the decision tree', leading to a neglect of aversive thoughts, and then subsequent actions, under optimal serotonin levels. Specifically, the increased non-reversal errors following the balanced drink may be a result of subjects successfully inhibiting punishment-related thoughts and actions, and hence making increased errors to expected punishment cues under balanced serotonin conditions. Reducing tryptophan (and hence putatively serotonin) may serve to remove this punishment-linked inhibition, releasing punishment responses, and bringing punishment errors down to the same level as reward errors. Errors following unexpected outcomes may, moreover, be impervious to this effect because (a) inhibitory processes may take more than one trial to be implemented (and reversal analysis only examines errors on the one trial following unexpected feedback) and/or (b) reversal trials require response switching which may mask any inhibitory effects.

Regardless of the interpretation, the present finding may be critical for our understanding of *resilience* to affective disorders. Specifically, increased inhibition of aversive thoughts may be an adaptive means to reduce the neuropsychological impact of aversive events which promotes, to a certain extent, *blissful ignorance* (Alloy and Abramson [@CR1]; Robinson et al. [@CR27]) and cushions against stress. Such inhibition might be removed by serotonin reduction (Cools et al. [@CR9]) and, in more naturalistic environments, via the recruitment of stress-specific neural networks (e.g. the amygdala (Cools et al. [@CR7])). Indeed *both* ATD and induced stress (via threat of shock) restore aversive processing which is reduced under non-anxious conditions (Robinson et al. [@CR27]). As such, on the flipside of the same coin, optimal levels of serotonin might promote resilience to affective disorders under non-anxious conditions by inhibiting responses to aversive stimuli.

Our failure to see an interaction between mood and ATD suggests that effects of ATD do not universally depend on mood. The previous demonstration of an interaction between mood and ATD (Robinson et al. [@CR25]) was seen in two complex tasks which required integration of information from multiple domains (i.e. self-referent recall and integrating pattern recognition with cued reinforcement) (Robinson et al. [@CR25]), but was not seen during affective inhibition (Robinson and Sahakian [@CR24]). As such, we previously argued (Robinson and Sahakian [@CR24]) that the mediating effect of mood may be restricted to tasks which require complex and integrative cortical processing rather than simple 'bottom up' activation of subcortical structures like the amygdala and striatum (which may be more basic, primal and fast responses that are not modulated by mood), but this is of course speculative and requires further study. It is notable that both tasks that fail to show an interaction involve affective inhibition, but of course the possibility that inadequate sample sizes account for the lack of effect should not be ruled out. It should be noted, furthermore, that the present mood induction technique was also adopted in both the study demonstrating an interaction (Robinson et al. [@CR25]), and the study failing to show an interaction (Robinson and Sahakian [@CR24]). As such, it is difficult to attribute this null effect to a failure of the manipulation. This finding thus argues against a universal role of mood state (Crockett et al. in submission) (e.g. negative mood associated with the procedure) in the effects of tryptophan depletion on cognitive processing (Feenstra and van der Plasse [@CR19]; van Donkelaar et al. [@CR30]).

It should also be noted that whilst the previous effect was seen within subjects, this study demonstrated the same effect between subjects. The present design has the advantage of ruling out order and sequence effects associated with repeating the same task in the same subjects, but it requires a larger sample size to achieve an equivalent level of sensitivity. Demonstrating remarkably similar effects with such different designs serves to enhance our confidence in the validity of our initial findings (Cools et al. [@CR10]).

The BAL group demonstrated a significant increase in tryptophan levels over the course of the day. This effect is seen in some (Crockett et al. [@CR12]; Robinson and Sahakian [@CR24]; Robinson et al. [@CR25]; Roiser et al. [@CR28]) but not all previous studies (Cools et al. [@CR10]; Robinson et al. [@CR25]). One implication of this observation is that we cannot precisely specify the direction of the effect. It is possible that tryptophan depletion enhanced punishment processing, as has been argued previously (Cools et al. [@CR9]; Crockett et al. [@CR12]), but it is also possible that tryptophan supplementation led to impaired punishment (relative to reward) processing, as has also been shown (Murphy et al. [@CR21], [@CR22]). If the latter, it could argue for the use of tryptophan supplementation as a means to promote resilience in healthy individuals (Elliott et al. [@CR17]; Murphy et al. [@CR22]), or to increase inhibition in disorders of impulsivity and compulsivity, such as attention deficit hyperactivity disorder (ADHD) and obsessive--compulsive disorder (OCD). Nevertheless, in our previous study with the same task, the same effect was seen under BAL despite no change of tryptophan ratios in this group (Cools et al. [@CR10]), so caution should be taken with this interpretation. Moreover, it is important to recognise that this ambiguity does not invalidate the central hypothesis that serotonin is involved in aversive inhibition. The hypothesis predicts increased inhibition following serotonin increases, as well as decreased inhibition following serotonin decreases. Nevertheless, this inability to specify the direction of the effect is a major weakness of the study. Future research might consider adding an additional baseline session without pharmacological manipulation to address this issue more directly. Fig. 1Tryptophan depletion removes a significant impairment in non-reversal punishment prediction which was present under the balanced condition. *Scores* represent untransformed error proportions, *error bars* are standard error of the mean;\**P* \< 0.05. *ATD* acute tryptophan depletion, *BAL* balanced drink, *REW* reward, *PUN* punishment

Conclusion {#Sec12}
==========

These findings demonstrate the facilitatory effects of ATD on punishment (and not reward) prediction, but extend them by showing them to be impervious to mood state. We argue that the effect may be due to tryptophan depletion removing serotonin-mediated inhibition of aversive thoughts, and hence actions, and that this may, moreover, reduce the psychological impact of negative life events and promote resilience to affective disorders. Disorders in which aversive processing is enhanced, such as anxiety and depression, as well as those in which inhibition is reduced, such as OCD and ADHD, are economically and emotionally costly to the individual and society. Increasing our understanding of how it might be possible to cushion against such disorders, potentially by enhancing behavioural inhibition to aversive stimuli, would go a long way towards improving the 'mental wealth of nations' (Beddington et al. [@CR3]).
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